Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read moreCurrent clinical guidelines for the treatment of eating disorders in Australia are aimed at treatments for medical and psychiatric care in line with the DSM-5 and International Classification of Diseases (ICD-10).
Read moreEating Disorders: A Professional Resource for General Practitioners has been updated to align with NEDC’s new resource, Eating Disorder Core Skills: eLearning for GPs.
Read moreFind information about the different types of eating disorders, according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), Fifth Edition, screening tools that can be used by health professionals to detect the possibility of an eating disorder and identify when a comprehensive assessment is warranted, such as Eating Disorder Screen for Primary Care (ESP), and a list of warning signs and responses.
Read more